Filed: 8/13/2024ACC: 0000950123-24-007977
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $215.45M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$215.45M
Total AUM (reported)
19.41M
Total Shares
Allocation by class
SHS$129.25M60.0%
COM NEW$86.19M40.0%
Portfolio Concentration
Top 3$215.45M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.41M
Sole
Full voting authority
19.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.23M
TypeSH
Market value$129.25M
59.99%
Sole
12.23M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares7.18M
TypeSH
Market value$86.19M
40.01%
Sole
7.18M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.23M | SH | $129.25M 59.99% | 12.23M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 7.18M | SH | $86.19M 40.01% | 7.18M | 0.00 | 0.00 |